0000000000599630

AUTHOR

Sharon Einav

showing 33 related works from this author

Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate

2019

Informazione non disponibile

medicine.medical_specialtyLetteracute respiratory failureRespiratory ratebusiness.industryMEDLINElcsh:Medical emergencies. Critical care. Intensive care. First aidOxygen Inhalation Therapylcsh:RC86-88.9high flow nasal therapyCritical Care and Intensive Care MedicineCannula Dyspnea Humans Oxygen Inhalation Therapy Patient Comfort Respiratory RateDyspneaRespiratory RateEmergency medicineNIVmedicineCannulaHumansAcute respiratory failurePatient ComfortCOTHigh flowbusiness
researchProduct

Additional file 2 of Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review

2021

Additional file 2. Online search strategy; Table S1; Table S2; Table S3. Description of data: additional file 2 contains the full online search strategy, Table S1 summarizing the characteristics of the included studies, Table S2 assessing the quality of the included studies and table S3 reporting the inclusion and exclusion criteria of the present review.

researchProduct

Procalcitonin levels in candidemia versus bacteremia: a systematic review

2019

Background Procalcitonin (PCT) is a biomarker used to assess systemic inflammation, infection, and sepsis and to optimize antimicrobial therapies. Its role in the in the differential diagnosis between candidemia and bacteremia is unclear. The aim of this systematic review was to summarize the current evidence about PCT values for differentiating candidemia from bacteremia. Methods PubMed and EMBASE were searched for studies reporting data on the diagnostic performance of serum PCT levels in intensive care unit (ICU) or non-ICU adult patients with candidemia, in comparison to patients with bacteremia. Results We included 16 studies for a total of 45.079 patients and 785 cases of candidemia. …

AdultMaleCalcitoninmedicine.medical_specialtyLetterBacteremiaCritical Care and Intensive Care MedicineProcalcitoninlaw.inventionSepsis03 medical and health sciences0302 clinical medicineBiomarker; Candida; Candidemia; Fungal; Fungi; PCT; Procalcitonin; SepsislawSecondary analysisSepsisparasitic diseasesmedicineHumansIntensive care medicineCandidaAdult patientsbusiness.industryResearchlcsh:Medical emergencies. Critical care. Intensive care. First aidFungiCandidemia030208 emergency & critical care medicinelcsh:RC86-88.9Biomarkermedicine.diseasebacterial infections and mycosesIntensive care unitFungalBacteremiaBiomarker (medicine)FemaleDifferential diagnosisbusinessPCTProcalcitoninhormones hormone substitutes and hormone antagonistsBiomarkersCritical Care
researchProduct

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review

2020

Abstract Background Tocilizumab is an IL-6 receptor-blocking agent proposed for the treatment of severe COVID-19. The aim of this systematic review was to describe the rationale for the use of tocilizumab for the treatment of COVID-19 and to summarize the available evidence regarding its efficacy and safety. Methods MEDLINE, PubMed, EMBASE, pre-print repositories (bioRxiv and medRxiv) and two trial Registries were searched for studies on the use of tocilizumab in COVID-19 or SARS-CoV-2 infection, viral pneumonia, and/or sepsis until 20th June 2020. Results We identified 3 indirect pre-clinical studies and 28 clinical studies including 5776 patients with COVID-19 (13 with a comparison group,…

Coronavirus COVID-19 Pneumonia SARS-CoV-2 TocilizumabGCA Giant cell arteritispJIA Pediatric juvenile idiopathic arthritislaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawMedicine030212 general & internal medicineClinical efficacyCPAP Continuous positive airway pressureCOVID-19 Coronavirus disease 2019IDSA Infectious Diseases Society of AmericaRA Rheumatoid arthritisTocilizumabIMV Invasive mechanical ventilationsJIA Juvenile idiopathic arthritisAIFA Agenzia Italiana del FarmacoPulmonary and Respiratory Medicinemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEAntibodies Monoclonal HumanizedNIH U.S. National Institutes of HealthArticleWHO World Health OrganizationSIMIT Italian Society of Infectious and Tropical disease03 medical and health sciencesTocilizumabARDS Acute respiratory distress syndromeAnimalsHumansIn patientIntensive care medicineTocilizumab ; COVID-19 ; Pneumonia ; SARS-CoV-2 ; Coronaviruslcsh:RC705-779business.industryCRS CAR-T cell-induced cytokine release syndromeInterleukin-6SARS-CoV-2NIV Noninvasive mechanical ventilationTNF Tumor necrosis factorCOVID-19Pneumonialcsh:Diseases of the respiratory systemCOVID-19 Drug TreatmentClinical trialCoronavirus030228 respiratory systemchemistrybusinessICTRP International Clinical Trials Registry PlatformPulmonology
researchProduct

Citations and metrics of journals discontinued from Scopus for publication concerns: the GhoS(t)copus Project

2020

Background: Scopus is a leading bibliometric database. It contains a large part of the articles cited in peer-reviewed publications. The journals included in Scopus are periodically re-evaluated to ensure they meet indexing criteria and some journals might be discontinued for 'publication concerns'. Previously published articles may remain indexed and can be cited. Their metrics have yet to be studied. This study aimed to evaluate the main features and metrics of journals discontinued from Scopus for publication concerns, before and after their discontinuation, and to determine the extent of predatory journals among the discontinued journals. Methods: We surveyed the list of discontinued jo…

0301 basic medicinemedicine.medical_specialtyGeneral Immunology and Microbiologymetricbusiness.industryScopusGeneral Medicinepredatory.General Biochemistry Genetics and Molecular BiologyDiscontinuation03 medical and health sciencesMisconduct030104 developmental biology0302 clinical medicinePublishingScopuFamily medicinejournalMedicineSubject areascitation countGeneral Pharmacology Toxicology and Pharmaceuticsbusiness030217 neurology & neurosurgeryindexingF1000Research
researchProduct

Cardiac arrest in older adult patients

2021

Purpose of review To describe the epidemiology, prognostication, and treatment of out- and in-hospital cardiac arrest (OHCA and IHCA) in elderly patients. Recent findings Elderly patients undergoing cardiac arrest (CA) challenge the appropriateness of attempting cardiopulmonary resuscitation (CPR). Current literature suggests that factors traditionally associated with survival to hospital discharge and neurologically intact survival after CA cardiac arrest in general (e.g. presenting ryhthm, bystander CPR, targeted temperature management) may not be similarly favorable in elderly patients. Alternative factors meaningful for outcome in this special population include prearrest functional sta…

medicine.medical_specialtyhealth care facilities manpower and servicesmedicine.medical_treatmentMEDLINE030204 cardiovascular system & hematologyTargeted temperature management03 medical and health sciences0302 clinical medicineHypothermia InducedEpidemiologyMedicineHumansCardiopulmonary resuscitationAgedResuscitation OrdersAged 80 and overAdult patientsbusiness.industry030208 emergency & critical care medicinemedicine.diseaseComorbidityhumanitiesCardiopulmonary ResuscitationHeart ArrestAnesthesiology and Pain MedicineEmergency medicineFunctional statusRisk classificationbusinessOut-of-Hospital Cardiac Arrest
researchProduct

Retracted papers on SARS-CoV-2 and COVID-19

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)preprintCOVID-19SARS-COV-2VirologyCOVID-19h-indexpreprintpublication ethicsretractionSARS-COV-2publication ethicsAnesthesiology and Pain MedicineCorrespondencePublication ethicsMedicineh-indexbusinessretractionBritish Journal of Anaesthesia
researchProduct

Inflated citations and metrics of journals discontinued from Scopus for publication concerns: the GhoS(t)copus Project

2020

AbstractBackgroundScopus is a leading bibliometric database. It contains the largest number of articles cited in peer-reviewed publications. The journals included in Scopus are periodically re-evaluated to ensure they meet indexing criteria and some journals might be discontinued for publication concerns. These journals remain indexed and can be cited. Their metrics have yet to be studied. This study aimed to evaluate the main features and metrics of journals discontinued from Scopus for publication concerns, before and after their discontinuation, and to determine the extent of predatory journals among the discontinued journals.MethodsWe surveyed the list of discontinued journals from Scop…

medicine.medical_specialtybusiness.industryFamily medicineScopusMedicineCitationbusinessDiscontinuationPeer review
researchProduct

The burden of peri-operative work at night as perceived by anaesthesiologists: An international survey

2023

Background: No international data are available on the night working conditions and workload of anaesthesiologists and their opinions about associated risks. Objective: The aim of this international survey was to describe the peri-operative night working conditions of anaesthesiologists and their perception of the impact these conditions have on patient outcomes and their own quality of life. Design: Cross-sectional survey. Setting: Not applicable. Participants: Anaesthesiologists providing peri-operative care during night shifts responded to an online survey promoted by the European Society of Anaesthesiology and Intensive Care (ESAIC). Interventions: None. Main outcome measure: Twenty-eig…

Anesthesiology and Pain Medicineanaesthesianighttime work
researchProduct

Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis

2022

PURPOSE: To describe data on epidemiology, microbiology, clinical characteristics and outcome of adult patients admitted in the intensive care unit (ICU) with secondary peritonitis, with special emphasis on antimicrobial therapy and source control. METHODS: Post hoc analysis of a multicenter observational study (Abdominal Sepsis Study, AbSeS) including 2621 adult ICU patients with intra-abdominal infection in 306 ICUs from 42 countries. Time-till-source control intervention was calculated as from time of diagnosis and classified into 'emergency' ( 6 h). Relationships were assessed by logistic regression analysis and reported as odds ratios (OR) and 95% confidence interval (CI). RESULTS: The…

AdultSecondary peritonitiCritical IllnessPeritonitisCritical Care and Intensive Care MedicineAnti-Bacterial AgentsAntimicrobial therapyIntensive Care UnitsSecondary peritonitisIntra-abdominal infectionAnti-Infective AgentsRisk FactorsSource controlSepsisMedicine and Health SciencesHumansIntraabdominal InfectionsMortalityRetrospective StudiesAntimicrobial therapy; Intra-abdominal infection; Mortality; Secondary peritonitis; Source controlIntensive Care Medicine
researchProduct

Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis.

2021

Abstract Aim To estimate the mortality rate, the rate of return of spontaneous circulation (ROSC) and survival with favorable neurological outcome in patients with COVID-19 after in-hospital cardiac arrest (IHCA) and attempted cardiopulmonary resuscitation (CPR). Methods PubMed, EMBASE, Web of Science, bioRxiv and medRxiv were surveyed up to 8th February 2021 for studies reporting data on mortality of patients with COVID-19 after IHCA. The primary outcome sought was mortality (in-hospital or at 30 days) after IHCA with attempted CPR. Additional outcomes were the overall rate of IHCA, the rate of non-shockable presenting rhythms, the rate of ROSC and the rate of survival with favorable neuro…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.medical_treatment030204 cardiovascular system & hematologyEmergency Nursing03 medical and health sciences0302 clinical medicinePrimary outcomeInternal medicineHospital dischargeMedicineHumansIn patientcprCardiopulmonary resuscitationMortalitybusiness.industrySARS-CoV-2Neurological statusMortality rateCOVID-19030208 emergency & critical care medicineCardiac arrestCardiopulmonary ResuscitationHospitalsHeart ArrestEditorialMeta-analysisEmergency MedicineCardiology and Cardiovascular MedicinebusinessResuscitation
researchProduct

Inclusion of pregnant women in clinical trials of COVID-19 therapies: what have we learned?

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Inclusion (disability rights)Pneumonia ViralMEDLINEArticlelaw.inventionBetacoronavirusRandomized controlled triallawHumansMedicinePregnancy Complications InfectiousIntensive care medicinePandemicsClinical Trials as TopicPregnancySARS-CoV-2business.industryPatient SelectionCOVID-19clinical trialmedicine.diseasedrug developmentClinical trialAnesthesiology and Pain MedicineDrug developmentFemalepregnancyCoronavirus Infectionsbusinessrandomised controlled trialBritish Journal of Anaesthesia
researchProduct

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

2020

Purpose COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is no known effective pharmaceutical treatment, although it is much needed for patient contracting the severe form of the disease. The aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of COVID-19. Methods PubMed, EMBASE, and three trial Registries were searched for studies on the use of chloroquine in patients with COVID-19. Results We included six articles (one narrative letter, one in-vitro study, one editorial, expert consensus paper, two national guideline documents) and 23 ongoing clinical trials in China. Chloroqui…

medicine.medical_specialtyChinaCoronaviruPneumonia ViralPsychological interventionMEDLINEDiseaseCritical Care and Intensive Care MedicineWorld Health OrganizationArticle03 medical and health sciencesAntimalarialsBetacoronavirus0302 clinical medicineChloroquinePandemicmedicineHumansIntensive care medicinePandemicsClinical Trials as Topicbusiness.industrySARS-CoV-2Public healthCOVID-19030208 emergency & critical care medicineChloroquinePneumoniaCOVID-19 Drug TreatmentClinical trialCoronavirusClinical researchTreatment Outcome030228 respiratory systembusinessCoronavirus Infectionsmedicine.drugJournal of Critical Care
researchProduct

Additional file 1 of Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review

2021

Additional file 1. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist. Description of data: compiled PRISMA-ScR checklist.

researchProduct

Being candid about Candida airway colonization and clinical outcomes: What can we really learn from unadjusted associations?

2020

Candida sppmedicine.medical_specialtyCross InfectionLung Diseases FungalEpidemiologybusiness.industryHealth PolicyRespiratory SystemPublic Health Environmental and Occupational HealthCandidiasisColony Count MicrobialInfectious DiseasesmedicineHumansColonizationAirwayIntensive care medicinebusinessAsymptomatic InfectionsCandidaAmerican journal of infection control
researchProduct

Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19

2020

Purpose To assess efficacy and safety of chloroquine (CQ)/hydroxychloroquine (HCQ) for treatment or prophylaxis of COVID-19 in adult humans. Materials and methods MEDLINE, PubMed, EMBASE and two pre-print repositories (bioRxiv, medRxiv) were searched from inception to 8th June 2020 for RCTs and nonrandomized studies (retrospective and prospective, including single-arm, studies) addressing the use of CQ/HCQ in any dose or combination for COVID-19. Results Thirty-two studies were included (6 RCTs, 26 nonrandomized, 29,192 participants). Two RCTs had high risk, two ‘some concerns’ and two low risk of bias (Rob2). Among nonrandomized studies with comparators, nine had high risk and five moderat…

ICU Intensive care unit;medicine.medical_treatmentCritical Care and Intensive Care MedicineRR Risk Ratio0302 clinical medicineChloroquineRCT Randomized clinical trialMedicineHCQ Hydroxychloroquine;Prospective StudiesProspective cohort studyChloroquine COVID-19 Hydroxychloroquine Mortality SARS-CoV-2ChloroquineECG Electrocardiogram;Rob2 Revised tool for Risk of Bias in randomized trials;CI Confidence interval;Coronavirus InfectionsPost-Exposure ProphylaxisHydroxychloroquinemedicine.drugmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEContext (language use)Antiviral AgentsArticleWHO World Health OrganizationBetacoronavirus03 medical and health sciencesInternal medicineHumansMortalityCOVID-19 Coronavirus disease 2019;Post-exposure prophylaxisPandemicsRetrospective StudiesCQ Chloroquine;SARS-CoV-2ROBINS-I Risk of Bias in Non-randomized Studies of Interventions;business.industryCOVID-19030208 emergency & critical care medicineHydroxychloroquineRetrospective cohort studyHCWs Healthcare workers;NOS Newcastle Ottawa Scale;COVID-19 Drug Treatment030228 respiratory systembusinessHR Hazard Ratio;Journal of Critical Care
researchProduct

Association between night-time extubation and clinical outcomes in adult patients

2021

Background: Whether night-time extubation is associated with clinical outcomes is unclear. Objective: The aim of this systematic review and meta-analysis was to evaluate the association between night-time extubation and the reintubation rate, mortality, ICU and in-hospital LOS in adult patients, compared with daytime extubation. Design: A systematic review and meta-analysis. Data sources: PubMed, EMBASE, CINAHL and Web of Science from inception to 2 January 2021 (PROSPERO registration - CRD42020222812). Eligibility criteria: Randomised, quasi and cluster randomised, and nonrandomised studies describing associations between adult patients' outcomes and time of extubation (daytime/night-time)…

AdultMechanical ventilationmedicine.medical_specialtyextubationCritical CareAdult patientsbusiness.industrymedicine.medical_treatmentRetrospective cohort studyCINAHLLength of StayDisease clusterRandom effects modelRespiration ArtificialIntensive Care UnitsAnesthesiology and Pain MedicineMeta-analysisIntensive careEmergency medicineAirway ExtubationmedicineHumansbusinessRetrospective StudiesEuropean Journal of Anaesthesiology
researchProduct

The challenge of the predatory open-access publishing outbreak

2019

NA

Anesthesiology and Pain MedicinePredatory publishingbusiness.industryOpen access publishingmedia_common.quotation_subjectInternet privacyMEDLINEMedicineOutbreakDeceptionbusinessethicsmedia_common
researchProduct

Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: A joint ESA/ESICM guideline.

2020

Hypoxaemia is a potential life-threatening yet common complication in the peri-operative and periprocedural patient (e.g. during an invasive procedure at risk of deterioration of gas exchange, such as bronchoscopy). The European Society of Anaesthesiology (ESA) and the European Society of Intensive Care Medicine (ESICM) developed guidelines for the use of noninvasive respiratory support techniques in the hypoxaemic patient in the peri-operative and periprocedural period. The panel outlined five clinical questions regarding treatment with noninvasive respiratory support techniques [conventional oxygen therapy (COT), high flow nasal cannula, noninvasive positive pressure ventilation (NIPPV) a…

Peri-operativePeriproceduralmedicine.medical_treatment[SDV]Life Sciences [q-bio]Critical Care and Intensive Care Medicinemedicine.disease_causeConference Report and Expert Panel0302 clinical medicine030202 anesthesiology[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesAnesthesiologyOxygen therapyMedicineContinuous positive airway pressureHypoxiaComputingMilieux_MISCELLANEOUS[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology[SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system3. Good health[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRespiratory InsufficiencyNasal cannulaHFNT[SDV.MP.PAR] Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyAdultmedicine.medical_specialtyCritical Care03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemAnesthesiologyIntensive careHumans[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyhypoxemiaNoninvasive Ventilationbusiness.industryOxygen Inhalation Therapy030208 emergency & critical care medicineEvidence-based medicineGuidelinePerioperative[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyVentilationNIV CPAPAnesthesiology and Pain Medicine030228 respiratory systemRespiratory failureEmergency medicine[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologybusinessHypoxaemiaHypoxaemia; Peri-operative; Periprocedural; VentilationEuropean journal of anaesthesiology
researchProduct

Choice of fluids in critically ill patients

2018

Background Fluids are by far the most commonly administered intravenous treatment in patient care. During critical illness, fluids are widely administered to maintain or increase cardiac output, thereby relieving overt tissue hypoperfusion and hypoxia. Main text Until recently, because of their excellent safety profile, fluids were not considered “medications”. However, it is now understood that intravenous fluid should be viewed as drugs. They affect the cardiovascular, renal, gastrointestinal and immune systems. Fluid administration should therefore always be accompanied by careful consideration of the risk/benefit ratio, not only of the additional volume being administered but also of th…

medicine.medical_specialtyResuscitationCritical CareCritical IllnessResuscitationCrystalloidDiseaseReview[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractlaw.inventionlcsh:RD78.3-87.3Sepsis03 medical and health sciences0302 clinical medicinelaw[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesAnesthesiologymedicineHumansIntensive care unit030212 general & internal medicineCardiac OutputIntensive care medicineCritically illFluidsRespiratory distressbusiness.industryAcute kidney injury030208 emergency & critical care medicinemedicine.diseaseIntensive care unit3. Good healthAnesthesiology and Pain Medicinelcsh:AnesthesiologyColloidFluid TherapyFluidbusinessAbdominal surgery
researchProduct

Citations and metrics of journals discontinued from Scopus for publication concerns: the GhoS(t)copus Project [version 2; peer review: 2 approved, 1 …

2020

Background: Scopus is a leading bibliometric database. It contains a large part of the articles cited in peer-reviewed publications. The journals included in Scopus are periodically re-evaluated to ensure they meet indexing criteria and some journals might be discontinued for 'publication concerns'. Previously published articles may remain indexed and can be cited. Their metrics have yet to be studied. This study aimed to evaluate the main features and metrics of journals discontinued from Scopus for publication concerns, before and after their discontinuation, and to determine the extent of predatory journals among the discontinued journals. Methods: We surveyed the list of discontinued jo…

lcsh:Rlcsh:Medicinelcsh:Qlcsh:ScienceF1000Research
researchProduct

Vasopressor and inotrope treatment for septic shock: An umbrella review of reviews

2021

Abstract Purpose To review the characteristics, findings and quality of systematic reviews (SRs) on the effect of any vasopressor/inotrope on outcomes in adult patients with sepsis compared with either no treatment, another vasopressor or inotrope or fluids. Materials and methods We systematically searched Cochrane Central Register of Controlled Trials, PubMed and Embase (January 1993–March 2021). Descriptive statistics were used. Results Among the 28 SRs identified, mortality was the primary outcome in most (26/28) and mortality was usually (23/28) studied using randomised controlled trials (RCTs). Fifteen SRs focused exclusively on patients with sepsis or septic shock. Sepsis and septic s…

AdultInotropemedicine.medical_specialtyBlindingmedia_common.quotation_subjectReviewCritical Care and Intensive Care MedicineNorepinephrine (medication)SepsisNorepinephrine03 medical and health sciencesCatecholamines0302 clinical medicineSepsisparasitic diseasesmedicineHumansMulticenter Studies as TopicVasoconstrictor Agentsmedia_commonSelection biasSeptic shockbusiness.industry030208 emergency & critical care medicinePublication biasmedicine.diseaseShock SepticSystematic review030228 respiratory systemEmergency medicinebusinessCardiotonic agentsSystematic Reviews as Topicmedicine.drugJournal of Critical Care
researchProduct

Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review

2021

Abstract Background The mortality of critically ill patients with COVID-19 is high, particularly among those receiving mechanical ventilation (MV). Despite the high number of patients treated worldwide, data on respiratory mechanics are currently scarce and the optimal setting of MV remains to be defined. This scoping review aims to provide an overview of available data about respiratory mechanics, gas exchange and MV settings in patients admitted to intensive care units (ICUs) for COVID-19-associated acute respiratory failure, and to identify knowledge gaps. Main text PubMed, EMBASE, and MEDLINE databases were searched from inception to October 30, 2020 for studies providing at least one v…

ARDSmedicine.medical_specialtyCritical Illnessmedicine.medical_treatmentReviewRespiratory physiologyCritical Care and Intensive Care MedicineHypoxemia03 medical and health sciencesMechanical ventilation0302 clinical medicineIntensive careFraction of inspired oxygenmedicineHumansIntensive care unitMechanical ventilation.Positive end-expiratory pressureMechanical ventilationRespiratory Distress SyndromeIntensive care unitsCoronavirus disease 2019Acute respiratory distress syndromebusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aidCOVID-19030208 emergency & critical care medicinelcsh:RC86-88.9medicine.diseaseRespiration Artificial030228 respiratory systemEmergency medicineRespiratory Mechanicsmedicine.symptombusinessCohort studyCritical Care
researchProduct

A Retrospective Study of the Proportion of Women at High and Low Risk of Intrauterine Infection Meeting Sepsis Criteria

2021

The Surviving Sepsis Campaign recently recommended that qSOFA not be used as a single parameter for identification of sepsis. Thus, we evaluated the efficacy of SIRS and qSOFA scores in identifying intrauterine infection. This case–control study evaluates SIRS and qSOFA criteria fulfillment in preterm premature rupture of membranes (n = 453)—at high infection risk—versus elective cesarean—at low infection risk (n = 2004); secondary outcomes included intrauterine infection and positive culture rates. At admission, 14.8% of the study group and 4.6% of control met SIRS criteria (p = 0.001), as did 12.5% and 5.5% on post-operation day (POD) 1 (p = 0.001), with no signifi…

Microbiology (medical)ChorioamnionitisEarly identificationchorioamnionitis; intrauterine infection; SIRS; sepsis; early identificationQH301-705.5VirologySepsisSIRSBiology (General)Intrauterine infectionMicrobiologyArticleMicroorganisms; Volume 10; Issue 1; Pages: 82
researchProduct

Chloroquine for COVID-19: rationale, facts, hopes

2020

The tragedy of the pandemic coronavirus disease 2019 (COVID-19) led to a desperate search for effective treatments. Chloroquine (CQ), an aminoquinoline used for many years for the prophylaxis and therapy of malaria and autoimmune diseases, has been put forward as a treatment option. The fact that CQ is not patented and has been in clinical use for years is a major advantage. CQ has been shown to have antiviral effects in SARS, MERS, Ebola, and HIV infections, but without data showing clinical effectiveness [1, 2]. Does the current level of evidence suffice for prescribing CQ for COVID-19?

Coronavirus disease 2019 (COVID-19)Treatment outcomeCoronaviruPneumonia ViralMEDLINECritical Care and Intensive Care Medicinemedicine.disease_causeAntiviral AgentsAntimalarialsBetacoronavirusChloroquinePandemicmedicineHumansPandemicsCoronavirusClinical Trials as Topicbiologybusiness.industrySARS-CoV-2lcsh:Medical emergencies. Critical care. Intensive care. First aidCOVID-19Chloroquinelcsh:RC86-88.9Pneumoniabiology.organism_classificationmedicine.diseaseVirologyCOVID-19 Drug TreatmentCoronavirusPneumoniaTreatment OutcomeEditorialbusinessCoronavirus InfectionsCOVID-19 ; Chloroquine ; Pneumonia ; SARS-CoV-2 ; CoronavirusBetacoronavirusmedicine.drug
researchProduct

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply

2021

lcsh:RC705-779Pulmonary and Respiratory Medicine2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19lcsh:Diseases of the respiratory systemAntibodies Monoclonal HumanizedSeverity of Illness Indexchemistry.chemical_compoundTocilizumabchemistrySeverity of illnessHumansMedicinebusinessIntensive care medicineLetter to the Editor
researchProduct

Additional file 1: of Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate

2019

List of included studies, search strategy, and risk of bias assessment. Detailed study methods, reference list of included studies, search strategy, risk of bias assessment. (DOCX 520 kb)

researchProduct

Additional file 1: of Procalcitonin levels in candidemia versus bacteremia: a systematic review

2019

Search output from PubMed. Full search output from PubMed. (DOCX 299 kb)

researchProduct

Additional file 2: of Procalcitonin levels in candidemia versus bacteremia: a systematic review

2019

Search output from EMBASE. Full search output from EMBASE. (DOCX 88 kb)

researchProduct

Association between night/after-hours surgery and mortality: a systematic review and meta-analysis

2020

Abstract Background The association between night/after-hours surgery and patients' mortality is unclear. Methods The protocol of this systematic review was registered in PROSPERO (CRD42019128534). We searched Medline, PubMed, and EMBASE from inception until August 29, 2019 for studies examining an association between timing of surgical procedures (time of anaesthesia induction or surgery start) and mortality (within 30 days or in-hospital) in adult patients. Studies reporting patients' mortality after surgery performed during the weekend only were excluded. All analyses were done using the random-effects model. Results We included 40 observational studies (36 retrospective and four prospec…

medicine.medical_specialtyMEDLINERisk AssessmentSensitivity and SpecificitysurgeryPatient safetyPostoperative ComplicationsAfter-Hours CareBiasnighttimepatient safetyRisk of mortalityHumansMedicineperioperativePropensity Scorebusiness.industryanaesthesiaOdds ratioPerioperativemortalityConfidence intervalSurgeryTreatment OutcomeAnesthesiology and Pain MedicineSurgical Procedures OperativeMeta-analysisoutcomeObservational studybusinessBritish Journal of Anaesthesia
researchProduct

Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units

2021

Severe intra-abdominal infection commonly requires intensive care. Mortality is high and is mainly determined by disease-specific characteristics, i.e. setting of infection onset, anatomical barrier disruption, and severity of disease expression. Recent observations revealed that antimicrobial resistance appears equally common in community-acquired and late-onset hospital-acquired infection. This challenges basic principles in anti-infective therapy guidelines, including the paradigm that pathogens involved in community-acquired infection are covered by standard empiric antimicrobial regimens, and second, the concept of nosocomial acquisition as the main driver for resistance involvement. I…

Drug Resistancemedicine.disease_causeSeverity of Illness Indexlaw.invention0302 clinical medicineENTEROBACTERIACEAElawDrug Resistance Multiple BacterialMedicine and Health SciencesPharmacology (medical)Cross InfectionbiologyBacterialAntimicrobialIntensive care unitAnti-Bacterial AgentsCommunity-Acquired InfectionsEuropeIntensive Care UnitsAnti-Bacterial Agents; Community-Acquired Infections; Critical Illness; Cross Infection; Europe; Humans; Intensive Care Units; Intraabdominal Infections; Microbial Sensitivity Tests; Peritonitis; Sepsis; Severity of Illness Index; Drug Resistance Multiple BacterialESCHERICHIA-COLI030220 oncology & carcinogenesisKLEBSIELLA-PNEUMONIAEBLOOD-STREAM INFECTIONSPYELONEPHRITISMultiplemedicine.medical_specialtyCritical IllnessMicrobial Sensitivity TestsPeritonitisEnterococcus faecalisNO03 medical and health sciencesIntra‑abdominal InfectionsAntibiotic resistanceFOODSepsisIntensive careInternal medicinemedicineHumansFLUOROQUINOLONE RESISTANCEPseudomonas aeruginosabusiness.industrySeptic shockMORTALITYbiology.organism_classificationmedicine.diseaseRISK-FACTORSIntraabdominal Infectionsbusiness030217 neurology & neurosurgeryEnterococcus faecium
researchProduct

Additional file 2: of Choice of fluids in critically ill patients

2018

Most relevant studies on fluids in critically ill patients discussed in the main text. Description of data: Table reporting relevant studies on fluids in critically ill patients retrieved by the systematic search (DOCX 151 kb)

researchProduct

Additional file 1: of Choice of fluids in critically ill patients

2018

Output of the systematic search. Description of data: Excel table reporting the output of the systematic search (XLSX 485 kb)

researchProduct